share_log

Mizuho Reiterates Buy on Axsome Therapeutics, Maintains $106 Price Target

Mizuho Reiterates Buy on Axsome Therapeutics, Maintains $106 Price Target

瑞穗重申买入axsome therapeutics,维持106美元的目标价
Benzinga ·  06/12 06:40

Mizuho analyst Graig Suvannavejh reiterates Axsome Therapeutics (NASDAQ:AXSM) with a Buy and maintains $106 price target.

瑞穗分析师Graig Suvannavejh重申买入axsome therapeutics(纳斯达克:AXSM),并维持106美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发